Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Science is a biotechnology company focused on accelerating the discovery and development of novel therapeutics through advanced computational and experimental methods. The company leverages a proprietary platform to identify high-value biological targets and optimize lead candidates across various therapeutic areas. By integrating data-driven insights with traditional drug discovery workflows, National Science aims to improve the efficiency and success rates of drug development programs. Their current efforts are primarily focused on early-stage research and establishing strategic partnerships within the life sciences ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Science.